GlaxoSmithKline Biologicals S.A.;Glaxo Group Limited
发明人:
BROWN, JAMES,METTENS, PASCAL,MURPHY, DENNIS
申请号:
PL09781057
公开号:
PL2315834T3
申请日:
2009.07.24
申请国别(地区):
PL
年份:
2018
代理人:
摘要:
The present invention is directed to a polypeptide which comprises: (i) an Rv2386c protein sequence; (ii) a variant of an Rv2386c protein sequence; or (iii) an immunogenic fragment of an Rv2386c protein sequence. In other aspects the invention is directed to associated polynucleotides, fusion proteins and methods for the treatment or prevention of tuberculosis.